Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced a historic agreement with the Trump ...

TrumpRx: Discover how Trump's new agreements with major pharmaceutical companies aim to lower prescription drug costs for ...

The deals will slash the prices of medicines for the government's Medicaid program and for cash payers in Trump's latest bid ...

Under the deals, each drugmaker will cut prices on most drugs sold to the Medicaid program for low-income people, senior ...

Under the deals, each drugmaker will cut prices on most drugs sold to the Medicaid program for low-income people, ...

Officials pledge ‘massive savings’ as companies agree to offer drugs at prices equal to those in other wealthy nations ...

On Friday, alongside leaders from Bristol Myers Squibb, Gilead Sciences, and Merck, among other leading pharma giants, the ...

President ​Donald Trump and nine major pharmaceutical companies ‌today announced deals that will slash the prices of their ...

Nine more drugmakers cut deals with the Trump administration. Not a subscriber? Sign up here to get this newsletter in your inbox. In today’s issue: The latest round of drug pricing deals. … How the ...

Washington: President Donald Trump and nine major pharmaceutical companies on Friday announced deals that will ...

Merck (MRK) announced it reached an agreement with the Trump administration to “ensure its prescription medicines are both accessible and ...

MRK faces looming Keytruda LOE, falling Gardasil sales and pricing pressure, but new products, pipeline and planned cost savings aim to offset the headwinds.